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Abstract
Background: There is an increasing need for animal disease models for pathophysiological research and efficient drug
screening. However, one of the technical barriers to the effective use of the models is the difficulty of non-invasive and
sequential monitoring of the same animals. Micro-CT is a powerful tool for serial diagnostic imaging of animal models.
However, soft tissue contrast resolution, particularly in the brain, is insufficient for detailed analysis, unlike the current
applications of CT in the clinical arena. We address the soft tissue contrast resolution issue in this report.
Methodology: We performed contrast-enhanced CT (CECT) on mouse models of experimental cerebral infarction and
hepatic ischemia. Pathological changes in each lesion were quantified for two weeks by measuring the lesion volume or the
ratio of high attenuation area (%HAA), indicative of increased vascular permeability. We also compared brain images of
stroke rats and ischemic mice acquired with micro-CT to those acquired with 11.7-T micro-MRI. Histopathological analysis
was performed to confirm the diagnosis by CECT.
Principal Findings: In the models of cerebral infarction, vascular permeability was increased from three days through one
week after surgical initiation, which was also confirmed by Evans blue dye leakage. Measurement of volume and %HAA of
the liver lesions demonstrated differences in the recovery process between mice with distinct genetic backgrounds.
Comparison of CT and MR images acquired from the same stroke rats or ischemic mice indicated that accuracy of volumetric
measurement, as well as spatial and contrast resolutions of CT images, was comparable to that obtained with MRI. The
imaging results were also consistent with the histological data.
Conclusions: This study demonstrates that the CECT scanning method is useful in rodents for both quantitative and
qualitative evaluations of pathologic lesions in tissues/organs including the brain, and is also suitable for longitudinal
observation of the same animals.
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Introduction
Animal models of pathological states, including genetically
engineered animals such as transgenic and knockout mice, as well
as induced and spontaneous disease models, are valuable for
mechanistic studies of similar disorders in humans. These animal
models are also useful for the rapid screening of pharmaceuticals
for action on a target specific to the disease being studied [1]. Until
recently, such studies have been labor-intensive because it is often
necessary to sacrifice significant numbers of animals under
different experimental conditions to fully diagnose their pathology,
severity, and rate of progression or remission. Therefore, there has
been a growing need to develop new non-destructive technologies
for more efficient studies with the animal models.
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and reported their novel characteristics relevant to the human
diseases they model. These include stroke-prone spontaneously
hypertensive rats (SHRSP) [2], PIT-BD (photochemically induced
thrombotic brain damage) mice [3], MCAO (middle cerebral
artery occlusion) mice [4], and PIT-LD (photochemically induced
thrombotic liver damage) mice [5]. These animal models have
been useful respectively for studying human spontaneous stroke
(cerebral infarction and/or hemorrhage), ischemic brain damage,
cerebral infarction, and ischemic liver injury. The main problems
with previous studies, including ours, however, were the labor-
intensiveness of the experimental procedures and the difficulty in
precise volumetric measurements. In our previous studies, for
instance, surgical manipulation to create the model was required
on dozens of animals for each experiment, and the brains or livers
of several treated animals and matched controls were sampled at
defined time-points after surgical induction of the disease (e.g., on
days 1, 4, 7 and 14). The organs from each animal were
subsequently fixed, sectioned, stained, and examined histologically
to measure the injured area of each organ from its serial sections
[3,6]. The lesion volumes were roughly estimated from the lesion
area and thickness of each section. These widely used protocols for
histopathological studies have advantages for detailed analysis of
the animal models through further application of histochemistry
and immunohistochemical staining. However, for studies in which
a specific treatment/surgery is needed for each animal and/or
individual variation has to be accounted for, this approach could
be disadvantageous because of its inefficiency, difficulty in
collecting sufficient numbers of samples, and inaccuracy.
Recent advances in imaging methods in clinical settings, such as
computed tomography (CT), magnetic resonance imaging (MRI),
and positron emission tomography (PET), have triggered the
extension of these technologies to studies of experimental animals
[1]. Nonetheless, these methods are not yet been commonly used
with experimental animals because of their significant costs and
poorer performance in comparison with corresponding clinical
equipment. However, the recently developed micro-CT scan can
be a cost-effective technique that provides high-resolution images
and rapid data acquisition from experimental animals, although its
use is limited by its relatively poor soft tissue contrast as compared
to human CT or other imaging techniques [1,7,8]. Therefore,
until recently, application of micro-CT imaging to small
experimental animals has been primarily restricted to skeletal
structures and adipose tissues. Further, while contrast-enhanced
CT imaging of organs such as liver has improved with the
development of the micro-CT scanner, specific contrast agents and
scan protocols [9,10], in vivo micro-CT imaging of the brain
remains a challenge because contrast resolution of the brain is
much lower than that of other organs [11]. Recently, several ex vivo
studies on cerebral vasculature and anatomy of mice and rats,
including one using isolated MCAO rat brain [12], have
demonstrated high spatial resolution and signal-to-noise ratio
[13,14,15]. Although a few in vivo trials of micro-CT imaging in
brain have reported acquisition of contrast-enhanced images of
injected blood or xenografted glioma [16,17], high-quality
imaging for advanced studies such as diagnostic imaging or
sequential study of animal disease models has not yet been
achieved.
The aims of this study were to examine whether i) brain CECT
is useful as a non-invasive method with high resolution and
accuracy for research on rodent disease models, ii) CECT for small
animals is applicable for studies such as serial observation of the
same animals and/or diagnosis of lesions in spontaneous disease
models, and iii) CECT could potentially be an alternative to
conventional histological approaches for diagnosis. To this end, we
employed a new micro-CT instrument in combination with
continuous administration of an iodine contrast agent, and
optimized CECT protocols for image acquisition in four different
disease models.
Materials and Methods
Animals
Male inbred BALB/c mice (Japan Crea) were purchased and
used for the generation of the MCAO and PIT-BD models. The
plasminogen knockout mice (Plg 2/2) and their wild-type
littermates (Plg +/+) with mixed backgrounds of C57BL/6J
(75%) and 129/SvJ (25%) were used for generating the PIT-LD
models [5,6]. Male SHRSP/Kpo rats (Experimental Animal
Facility at Kinki University School of Medicine) were used as a
spontaneous stroke model. All animals were cared for in
accordance with the Law (No. 105) and Notification (No. 6) of
the Japanese government, and all experiments were conducted
with the permissions of the Experimental Animal Welfare
Committees of Kinki University (KAME019-039, KAME19-026,
KAME-19-047 and KAME-19-050) and Osaka University (FBS
07-001).
Animal disease models
The MCAO, PIT-BD and PIT-LD models were generated as
previously described [3,6]. Briefly, these mouse models were
generated as follows.
The MCAO model. Under 2% isoflurane anesthesia, the
skull was exposed and a small opening was made in the upper
region of the zygomatic arch with a handheld drill. The middle
cerebral artery was occluded by ligation with nylon thread (10-0;
Johnson and Johnson).
The Photochemically Induced Thrombotic (PIT)
models. The PIT models (PIT-BD and PIT-LD, as described
below) are ischemic injury models induced by in vivo
administration of a photo-reactive dye (Rose Bengal) followed by
the activation of the dye in a selected area of the brain or liver by
green light irradiation resulting in the generation of reactive
oxygen species, which lead to thrombosis in the area adjacent to
the light source [3,6,18,19].
i) The PIT-BD model: Under isoflurane anesthesia, a cannula was
inserted into the jugular vein. The skin on the top of the head was
incised, and an optic fiber (1.0 mm in diameter) was placed on the
skull. Immediately after the infusion of 20 mg/kg Rose Bengal
(Wako Pure Chemicals) through the cannula, the brain area
adjacent to the optic fiber was illuminated with green light
(wavelength, 540 nm; illumination intensity, 4.7610
24 W/cm
2)
for 10 min using a heat-absorbing light source (model L5178,
Hamamatsu Photonics). After illumination, the incised skin was
sutured under sterile conditions and the cannula was withdrawn.
ii) The PIT-LD model: The left lateral liver lobe was exposed after
laparotomy under isoflurane anesthesia, and an optic fiber (3 mm
in diameter) was allowed to gently touch the center of the lobe.
The right jugular vein was cannulated with a polyethylene tube
containing saline and connected to a microinjection pump. Rose
Bengal (10 mg/kg) dissolved in saline was infused at a rate of
50 ml/min followed immediately by illumination with green light
(wavelength, 540 nm; illumination intensity, 2.36610
22 W/cm
2)
for 10 min by using the above light source (model L5178).
The human stroke or hypertensive encephalopathy
model. The SHRSP/Kpo rat was used as a spontaneous
model of human stroke or hypertensive encephalopathy [20–22].
Systolic blood pressure (SBP) and heart rate were measured by
In Vivo Diagnostic Imaging of Rodents by Micro-CT
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throughout the experiments. Typically, SBP was over 230 mm
Hg in the SHRSP rats. Body weight was measured every day.
Stroke incidence was estimated based on blood pressure and heart
rate measurements, body weight, and neurological symptoms as
described previously [23].
Contrast enhanced micro-CT (CECT) imaging
In vivo CECT imaging was performed with an X-ray CT system
(Latheta LCT-200, Hitachi Aloka Medical) newly developed for
imagingsmall experimental animals.Each experiment included3–5
animals (see Results). Mice were anesthetized with isoflurane,
and Iohexol, an iodine contrast medium with a concentration of
300 mg iodine/ml (mg I/ml; Daiichi-Sankyou, Tokyo), was infused
intravenously at a rate of 5 ml/hr for 5 min before CT scanning,
followed by a continuous infusion rate of 1 ml/hr during the entire
CT examination. For rats, the infusion rate was 30 ml/hr for 5 min
before the CT scan, followed by a continuous infusion rate of 6 ml/
hr during image acquisition. Parameters used for the CT scans were
as follows: tube voltage: 50 kV; tube current: 0.5 mA; axial field of
view (FOV): 60 mm for rats and 48 mm for mice, with an inplane
spatial resolution of 48 mm648 mm and slice thickness of 192 mm
for the liver and 384 mm for the brain. Images were generated by
integration of four and eight signal averages, respectively, for the
liver and brain, and image acquisition for the liver was respiratory-
gated. Total scan time was approximately 15 min for the liver and
20 min for the brain. Quantitative assessment of the lesion area was
performed with LaTheta software (version 3.00). Three-dimension-
al CT pictures of the brain and liver were reconstructed with the
VGStudio MAX2.0 software (Nihon Visual Science, Tokyo, Japan).
To diagnose and analyze brain lesions of the MCAO, PIT-BD, and
SHRSP models by CECT, high attenuation area (HAA) was set at
CT values higher than 150, and low attenuation area (LAA) at CT
values less than 80, based on the average CT values obtained from
the acquired images. HAA at CT values of higher than 450, and
LAA at those of less than 300 were used for measuring injury in
PIT-LD mice.
Micro-magnetic resonance imaging (micro-MRI)
An MRI apparatus for small animals at 11.7 T (Bruker,
AVANCE 500WB) was used for the experiments. Rats (SHRSP,
n=5) or mice (MCAO, PIT-BD and PIT-LD, n=4 each) were
anesthetized with isoflurane and MRI was performed under the
following conditions:
i) For the rat study, T2-weighted fast spin echo (Rapid
Acquisition with Relaxation Enhancement: RARE) sequence
(TR/TE=6000/45 ms; FOV=25625 mm; matrix
size=2566256; slice thickness=0.5 mm; NS=16; total scan
time=25 min approx.) and T1-weighted gradient echo (Fast
Low Angle Shot: FLASH) sequence (TR/TE=300/2.6 ms;
FOV=25625 mm; matrix size=2566256; slice thick-
ness=0.5 mm; NS=8; total scan time=6 min approx.)
were used.
ii) For the mouse brain study, T2-weighted fast spin echo
(RARE) sequence (TR/TE=5000/35.4 ms; FOV=256
25 mm; matrix size=2566256; slice thickness=0.5 mm;
NS=8; total scan time=10 min approx.) was used.
iii) For the mouse liver study, T2-weighted fast spin echo
(RARE) sequence (TR/TE=5000/36 ms; FOV=206
20 mm; matrix size=2566256; slice thickness=0.5 mm;
NS=8; total scan time=10 min approx.) was used.
Histology
Following the CT scan or MRI, mice and rats were anesthetized
and perfused with 4% paraformaldehyde. The brain or liver was
removed, embedded in paraffin, sectioned, and used for
histological analyses. Sections were stained with hematoxylin
and eosin (H&E) according to standard protocols. For the
detection of ischemia, 2% 2,3,5-triphenyltetrazolium chloride
(TTC) staining was performed on the brain sections (1-mm
thickness).
Assessment of vascular permeability
Blood-brain barrier permeability was measured using Evans
blue dye leakage as described elsewhere [24]. Briefly, after CECT
and MR scans were performed on the MCAO and PIT-BD mice
(n=5 each), 200 mg/kg body weight of a 4% solution of Evans
blue in saline was injected intravenously. 90 min after injection,
animals were sacrificed and were perfused with 20 ml of saline
through the left heart. The brain was removed and sectioned in 2-
(MCAO) or 3-mm (PIT-BD) segments. Then all slices were
sectioned in the middle, and ipsilateral (including the ischemic
area) and contralateral (control) segments were collected separate-
ly. Formamide (300 ml) was added in each tube containing the
tissue sections and incubated at 55uC for 72 h to extract Evans
blue dye. The absorbance at 620 nm of the supernatant was
measured and the amount of Evans blue in each hemisphere was
calculated from a standard curve. The difference between the
ipsilateral and contralateral hemispheres was considered to
represent the amount of extravasated Evans blue in the lesion.
Statistics
For Figs. 1, 2, 3, Two-way analysis of variance (ANOVA) with
Bonferroni post-hoc tests and Kruskal-Wallis test with Dunn’s
post-hoc tests for multiple comparisons were performed by using
Prism software (GraphPad Software Inc.). For Figs. S2 and S3,
paired t-tests were performed. P,0.05 was considered statistically
significant.
Results
Time-dependent changes in MCAO-induced cerebral
infarction as revealed by micro-CECT
We first performed CECT using the MCAO mice, which are
widely used as a model of cerebral infarction (n=3). Using the
optimized parameters (see Methods), we could non-invasively and
sequentially examine cerebral infarction of the same MCAO mice
from one day through two weeks after arterial occlusion (Fig. 1A).
To assess infarction qualitatively and quantitatively, we measured
the volume of the damaged area by setting a threshold of the CT
value as described in Methods (Fig. 1B). On the first day after
surgical occlusion (day 1), the infarct area was readily observed as
LAA, indicating edema or a lack of penetration of the contrast
agent due to a lack of blood flow in the affected area. In contrast,
between days 3 and 7, HAA/(LAA+HAA) (%HAA) was increased,
suggesting enhanced vascular permeability in the infarct area in
the brain. To quantify these processes, we measured infarction
volume in the areas of low and high attenuation and compared the
%HAA values. As shown in Fig. 1B, lesion volume (LAA+HAA)
decreased gradually over time until day 14. The LAA-indicating
infarct area was predominant on day 1 (%HAA was 0 for all
animals examined), but from day 7 through day 14 LAA was not
detected and HAA was observed exclusively in the lesion (Fig. 1C,
%HAA was 1 for all animals). To confirm the location and size of
the infarct area, separate mice were sacrificed immediately
following CECT image acquisition on selected days after the
In Vivo Diagnostic Imaging of Rodents by Micro-CT
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Figs. 1D and E are representative brain slices from MCAO mice at
day 7, stained by TTC or treated by Evans blue, respectively.
Consistent with the CECT images (Fig. 1A, F), infarction was
observed in the right cerebral cortex (Fig. 1D). Leakage of Evans
blue observed in the infarct area indicated increased vascular
permeability in the region (Fig. 1E, S1), which is consistent with
the increase of the HAA detected by CECT (Fig. 1A–C).
The PIT-BD brain demonstrated similar changes in the
damaged area comparable to the MCAO model
The PIT-BD mouse is another model for ischemic brain injury
in which a certain area of the cerebral cortex is photochemically
damaged to cause ischemia [3]. To test whether this model
demonstrates a pattern comparable to that of the MCAO mice, we
examined PIT-BD mice by CECT as described in Methods (n=3,
Fig. 2). Similar to the CECT images observed in the MCAO mice,
the lesion area of the PIT-BD mice showed low attenuation on day
1 (Fig. 2A, B). On days 3 and 5, the %HAA gradually increased,
and only HAA was observed on day 7 and 14. The volume of the
lesion area (HAA+LAA) decreased over time in a manner similar
to that in the MCAO mice (compare Fig. 1B and 2B). Constant
elevation of the %HAA seen in MCAO (Fig. 1C) was also
observed in the damaged area in the PIT-BD mice (Fig. 2C).
Histological studies of the PIT-BD brains (Fig. 2D, E) demon-
strated that, although the average volume of the infarction in the
PIT-BD mice was significantly smaller than that of MCAO
(compare Figs. 1B and 2B, also 1F and 2F), points of similarity in
measure, such as increased permeability in the lesion, were
observed between the MCAO (Fig. 1B) and PIT-BD models
Figure 1. Temporal changes in cerebral lesions in the MCAO mouse infarction model. A. Representative serial CECT images acquired from
the same MCAO mouse brain scanned over a two week period. The red arrow indicates the infarct region. B. Quantitative changes in the lesion area
of the MCAO brain over time. Changes in lesion volumes of three MCAO mice through days 1 and 14 were plotted. C. Progressive changes in the ratio
of the HAA (%HAA) in the same MCAO mice shown in B. D. A coronal brain slice of an MCAO mouse on day 7 stained with TTC. The ischemic lesion is
indicated by the arrow. E. Increased vascular permeability in the lesion shown by Evans blue leakage. F. A three-dimensional (3-D) image of the
infarct area in an MCAO brain (white area, arrow) reconstructed from sequential coronal CECT images. All scale bars indicate 1 mm (A, D, E).
doi:10.1371/journal.pone.0032342.g001
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(Fig. 2E, S1) was also consistent with the increase in the %HAA
observed by CECT (Fig. 2B, C)
Assessment of vascular permeability by Evans blue
leakage
As we had observed elevated %HAA in the lesions of the
MCAO and PIT-BD brains, we then measured the amount of
Evans blue extravasated from the brain lesions, which is
considered to reflect vascular (Blood-brain barrier) permeability
(see Materials and Methods). After intravenous injection of the
dye, we measured the amounts of the dye leaked into the ipsilateral
hemisphere (including the lesion) as compared with those in the
contralateral hemisphere (control) of the same animals (n=5 for
each animal model). As shown in Fig. S1, the average amount of
dye extracted from the ipsilateral specimen (ipsi.) was significantly
higher than that from the other half of the cerebrum (contra.) in
both of the two animal models, indicating elevated vascular
permeability in the lesion area of the brain.
Differences in recovery from liver damage between
wild-type and plasminogen-knockout mice
We performed CECT imaging studies of mice with ischemic
liver injury, PIT-LD, and compared the effects of plasminogen
(Plg) gene deficiency on liver injury and subsequent recovery
(Fig. 3, S2; n=4). The volume of the damaged area in the PIT-LD
mice of the wild-type background (Plg +/+, WT) decreased over
four days (Fig. 3A, B, S2A, C, E), and the lesion became
Figure 2. Temporal changes in the infarct area in the PIT-BD mouse model. A. Serial CECT images taken from a representative PIT-BD
mouse brain. B. Time-dependent changes in %HAA and total volume of lesion. Changes in lesion volumes of three MCAO mice through days 1 and
14 are shown. C. Temporal changes in %HAA in the same PIT-BD mice shown in B. There were significant differences in %HAA between day 1 and
days 7 and 14 (Kruskal-Wallis test with Dunn’s post-hoc tests, *P,0.05). D. A TTC-stained coronal section of a PIT-BD mouse brain on day 7. The arrow
indicates the ischemic lesion. E. Leakage of Evans blue indicating elevated vascular permeability in the infarct area. F. A 3-D image of the PIT-BD
lesion (white area) reconstructed from sequential CECT images. Scale bars: 1 mm (A, D, E).
doi:10.1371/journal.pone.0032342.g002
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contrast, in the plasminogen-knockout mice (Plg 2/2, KO), the
decrease of the lesion volume was slower than that of the WT
controls (Fig. 3A, C, S2B, D, F). Two-way ANOVA with post-hoc
tests for multiple comparisons revealed that there are significant
differences in the lesion volumes between KO and WT mice on
days 4, 7, and 14 (Fig. 3B; {, P,0.001, {, P,0.0001, 1,
P,0.0001). Of note, HAA was observed over the entire period of
the study in mice of both genotypes, primarily in the marginal
areas of the legion (Fig. 3A–C). Evans blue treatment demon-
strated that the HAA at the border of the liver lesion overlapped
with the region where intense Evans blue stain was observed (Figs.
Figure 3. Differences in the temporal changes in liver lesions between the WT and plasminogen KO mice. A. CECT scans showing time-
dependent recovery from PIT-LD liver injury in wild-type (WT), but not in the plasminogen-knockout (KO) mouse. The arrows indicate areas of
photochemically induced injury. Scale bars indicate 2 mm. B. Quantitative evaluation of the recovery process from the liver damage in the WT mice.
Changes in lesion volumes in WT PIT-BD mice from day 1 through day 14 are shown (n=4). Kruskal-Wallis test with Dunn’s post-hoc tests indicated a
significant difference in the lesion volumes between days 1 and 14 (***, p,0.001). Two-way ANOVA with Bonferroni post-hoc tests revealed
significant differences in the lesion volumes between WT and KO mice on days 4 ({, P,0.001), 7 ({, P,0.0001) and 14 (1, P,0.0001). C. Changes in
the lesion volume in livers of the plasminogen KO mice over the two weeks with a significant reduction in lesion size between days 1 and 14
(*, p,0.05 by Kruskal-Wallis test with Dunn’s post-hoc tests). D. H&E-stained vertical sections at the center of the liver lesion in WT (upper panels) and
plasminogen-KO mice (lower panels). Arrowheads indicate granulation tissue, which was not observed in the KO mouse liver. Scale bars: 1 mm.
doi:10.1371/journal.pone.0032342.g003
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WT and KO mouse liver was confirmed by histological analysis
(Fig. 3D). Whereas the infarct area in the liver in WT mice
decreased gradually, no significant change in the liver lesion area
was observed in KO mice. High cellular layers (Fig. 3D,
arrowheads), where the accumulation of macrophages, neutrophils
and active hepatic stellate cells, collagen fiber deposition, and
angiogenesis were previously reported [6], were observed in the
WT, but not in the KO, mouse livers. Interestingly, despite this
histological difference between the WT and KO mice, the HAA at
lesion margins was detected by CECT in mice of both genotypes
(Fig. 3A).
Comparative volumetric analyses of the brain/liver
lesions using CT and MRI
To examine whether the total lesion volumes of the MCAO,
PIT-BD, and PIT-LD mice that we measured by CECT were
accurate, we next performed comparative volumetric analyses of
the same animals using micro-CT and micro-MRI (Fig. S3). The
MCAO and PIT-BD mice (n=4 each) on day 7 and the PIT-LD
mice (n=4) on day 4 were sequentially scanned by CT and MRI,
and acquired images as shown in Fig. S3A were used for
volumetric analyses as performed for the experiments shown in
Figs. 1–3. Fig. S3B shows the lesion volumes of the three different
model mice measured from CT and MR images. There was no
significant difference in the lesion volumes calculated by the two
different image acquisition techniques.
Comparison of CECT and micro-MRI for the detection of
stroke areas in the SHRSP brain
We next studied the SHRSP rats with CECT as a representative
model of spontaneous brain disease. These rats exhibit individual
differences in their symptoms, e.g., onset, severity, lesion size and
localization. To determine whether images acquired by CECT
have sufficiently high resolution and whether small infarction/
hemorrhage in the brain can be detected as with micro-MRI, we
compared the CT images of the brain from the same diseased
SHRSP animals with the MR images (n=5). As shown in Fig. 4,
the spatial and contrast resolution of the ischemic lesion on micro-
CT images was comparable to that of the micro-MR images
(Fig. 4A–C). Fig. 4A shows images acquired from CECT, T2-
weighted MR (T2WI), and H&E-stained section of the same stroke
areas in an SHRSP rat brain at 2 weeks from the onset. Wedge-
shaped HAAs were observed by CECT, suggesting increased
permeability. The T2WI images of the corresponding lesion
showed a low signal in the central region surrounded by a high-
signal area, suggesting suspected hemorrhagic infarction. The
H&E stained sections of infarct areas demonstrated gliosis and
inflammatory cell infiltration either surrounded by a necrotic area
(upper) or with partial hemorrhagic transformation (lower). Fig. 4B
shows images acquired from CECT, T2WI, and T1-weighted
gradient echo (GRE) along with an H&E stained section of the
same stroke area in a different SHRSP rat brain after 3 weeks from
the onset. HAA was detected by CECT, the co-existence of high
and low signals was observed in the T2WI image, and low signal
was observed in the GRE image, suggesting a suspected
hemorrhagic infarction of about 0.5 mm in diameter. Histological
analysis indicated cystic cavity formation with gliosis. Fig. 4C
shows images from the same stroke areas in an SHRSP rat brain
after 4 weeks from the onset. Wedge-shaped LAAs (Fig. 4C, red
and white bold arrows) were observed by CECT, low and high
signals were detected in T2WI, and low signal was observed in
GRE, suggesting suspected hemorrhagic infarction. H&E images
showed cystic cavity formation with gliosis and inflammatory cell
infiltration (Fig. 4C, lower panels). We also detected a smaller
lesion in the same rat brain (Fig. 4C, thin arrows) for which HAA
in CECT and low signals in T2WI and T1-GRE were observed,
suggesting hemorrhage. Histological analysis of the lesion
confirmed hemorrhage of about 0.1 mm in diameter (H&E,
upper panel). Fig. 4D demonstrates a different brain area of the
Figure 4. Comparisons of the CT and MR images of stroke
lesions in the SHRSP rats. A. Images acquired with CECT (left), T2-
weighted MR (T2WI, middle), and H&E staining (right) of the same
stroke areas in an SHRSP rat brain two weeks after the onset. The areas
indicated by arrows are suspected loci of hemorrhagic infarction. Infarct
lesions with gliosis and inflammatory cell infiltration were observed in
the upper and lower H&E images (left and right panels are the same
lesion at low and high magnifications, respectively). Hemorrhage (or
congestion) is also seen in the lower panels. Scale bars: 2 mm (CECT);
400 mm (H&E). B. Images acquired by CECT, T2WI, and T1-weighted
gradient echo (GRE), along with an H&E image of identical stroke areas
in an SHRSP rat brain after 3 weeks of stroke onset. Arrows indicate
suspected hemorrhagic infarction of about 0.5 mm in diameter. Gliosis
and small-sized cystic cavity formation are observed in the infarct area
(H&E image). Scale bars: 2 mm (CECT), 100 mm (H&E). C. Images
obtained with CECT, T2WI, T1-weighed GRE, and an H&E stain of
identical stroke areas in an SHRSP rat brain 4 weeks after onset. Bold
arrows (red and white) in upper panels indicate suspected hemorrhagic
infarction. A suspected hemorrhage of about 0.1 mm in diameter was
also detected (thin arrows). The corresponding areas were analyzed by
H&E staining (upper right and lower panels). The lesion areas indicated
by both red and white bold arrows in the H&E images are wedge-
shaped infarcts with inflammatory cell infiltration, gliosis, and cystic
cavities (lower panels at low and high magnifications). Scale bars: 2 mm
(CECT), 500 mm (H&E, white bars) and 100 mm (H&E, black bars). D.
Images of the posterior brain of the same SHRSP rat shown in C. The
bold arrow indicates a suspected hemorrhagic infarction. Scale bars
indicate 2 mm (CECT) and 500 mm (H&E, lower panel).
doi:10.1371/journal.pone.0032342.g004
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in CECT and low signals in T2WI and T1-GRE suggest
hemorrhagic infarction, which was confirmed by H&E staining
(Fig. 4D). In summary, we could detect infarction and/or
hemorrhage in all rats we examined by either imaging method.
Discussion
In this study, contrast-enhanced micro-CT was performed on
different rodent models of ischemic/hypertensive diseases. We
successfully detected brain injury or stroke in the mouse/rat brain
with high spatial and contrast resolutions by continuous
administration of a clinically-used iodinated contrast agent,
Iohexol. Simple CT imaging and/or use of a bolus dose injection
of contrast agent are not suitable for brain and liver imaging in
rodents due to the low contrast resolution of micro-CT scans and
rapid excretion of the contrast agent in these species (Fig. S4). It
should be noted that the high infusion rates of the contrast agent
did not cause lethality or severe damage to the animals used in this
study. Thus, the CECT methods we describe here are practical for
soft tissue imaging, including respiratory-gated liver image
acquisition and brain imaging. The low attenuation areas (LAA)
found in the ischemic brain on day 1 by CECT were consistent
with the infarct area detected by histology. In addition, our CECT
study using two independent ischemic mouse models also
demonstrated that the LAA decreased from day 3, becoming
undetectable by day 7, and were gradually replaced by HAA. The
volumetric measurements by CECT were comparable with those
by MRI, suggesting that the quantitative analyses based on the
images acquired from CECT are accurate and reliable (Fig. S3).
Furthermore, the changes in vascular permeability were confirmed
by the measurement of Evans blue dye leakage. These data suggest
that lesion volume and the degree of vascular permeability of the
infarct area can be assessed by measuring lesion volume or %HAA
using our CECT methods. We also demonstrate by comparison of
the images acquired from micro-CT and micro-MRI (11.7 T)
from the rat stroke model that CECT can detect infarct or
hemorrhagic areas at a resolution of less than 0.5 mm in diameter,
which is comparable to the detection limits of the high-end micro-
MRI. We further performed comparative volumetric analyses
using CECT and MRI, demonstrating that average lesion volumes
measured by the two different image acquisition techniques are
comparable with each other. The data suggest that volumetric
measurement using our CECT methods is quite reliable.
Our study also demonstrates that sequential monitoring of the
same animal over time with all these animal models can reveal
quantitative and qualitative alterations of lesions, suggesting that
this non-invasive, serial approach is beneficial and efficient for
studying pathological changes in vivo. For instance, the volumes of
the lesion areas (LAA+HAA) in the MCAO and PIT-BD mice
gradually decreased, and %HAA was elevated until LAA became
undetectable after one week (Figs. 1, 2). The data also suggest that
vascular permeability is increased in the infarct area for the first
week, followed by a decrease in the volume of damaged area over
time. Consistent with the previous studies [5], we have also
demonstrated that, while the lesion volume of the PID-LD liver in
WT mice decreased over time, the volume of the liver lesion in the
plasminogen KO mice was not significantly reduced (Fig. 4). The
ischemic liver lesion was surrounded by HAA, which was manifest
in the majority of the lesion areas from day 1 through day 14 in
both the plasminogen KO and WT animals. It has previously been
reported that, in the marginal region of the liver lesions in WT
animals, inflammatory cell and fibroblastic cell infiltration, as well
as neovascularization, is observed [5,6]. Although these normal
biological responses are not observed in the plasminogen KO
mice, our CECT data demonstrating HAA in the KO mice liver
lesions imply qualitative changes in the damaged area, such as
increased vascular permeability or congestion.
The MCAO and PIT-BD mouse brain images acquired from
CECT demonstrated similar patterns in temporal changes in the
ischemic areas, where average lesion volume (LAA+HAA)
declined and %HAA increased, indicating that vascular perme-
ability progressively increased during the first week of observation
(Figs. 1, 2). The data presented here have demonstrated not only
that these quantitative and qualitative evaluations are consistent
with those previously reported, but also that we could concurrently
compare the two independent brain ischemia models by imaging
several animals in a few hours. In addition, such experiments can
also be applied to monitoring groups of inbred animals that show,
for instance, individual variation in phenotypes or varying
responses to drug candidates. Given that analogous pathological
trends were observed in the two ischemic models as well as in
humans, our data support the view that these mice are good
models for human ischemia.
Our comparative study of micro-CT and micro-MRI using the
SHRSP stroke model has demonstrated that small hemorrhage or
infarction in the brain (0.5 mm or less in diameter) can be detected
by the CECT (Fig. 4B, C). The data suggest that the spatial and
contrast resolutions of the micro-CT images of the brain are
sufficient for analyzing strokes in this small rodent model. By
contrast, micro-MRI is more informative for diagnosis of stroke, as
different clinical phases (super acute, acute, subacute, or chronic)
can be precisely determined. However, issues with current micro-
MRI are: i) it is relatively costly, ii) it requires special skill for
parameter settings, and iii) it requires a facility for a high magnetic
field. In contrast, the micro-CT does not have any restrictions for
installation or requirements for a radiation shield. In addition to its
cost-effectiveness and easy-to-use features, micro-CT also provides
high-resolution images and rapid data acquisition capabilities [1],
which should encourage the use of micro-CT in future studies.
In summary, our present study has demonstrated the utility and
the advantages of micro-CT in studying pathological animal
models. First, this non-invasive in vivo imaging in small animals
facilitates longitudinal monitoring of individual animals in
experiments. Therefore, this method can reduce number of
animals need for such studies and accelerate the pathophysiolog-
ical understanding of disease processes and screening of thera-
peutic compounds. Second, micro-CT imaging provides precise,
reliable, and detailed information on pathological changes in soft
tissues. As shown in this study, the results obtained by imaging
were consistent with those from conventional histological studies.
In addition, repeated monitoring over time of the same animals
would enable accurate quantitative and qualitative studies of
particular lesions. Third, this non-invasive approach would be
valuable for preclinical research. For instance, longitudinal micro-
CT monitoring is advantageous for preclinical research, as this
approach cannot be applied in human clinical studies due to high
radiation doses or other ethical issues. Thus, further translational
studies on pathological models using the micro-CT technique
would also provide knowledge for preemptive medicine.
Supporting Information
Figure S1 Increased vascular permeability in the
MCAO and PIT-BD mouse lesions. Evans blue dye was
injected intravenously and average amounts of extravasated dye
were calculated for brain slices from injured (ipsilateral) and
control (contralateral) hemispheres of the MCAO and PIT-BD
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contralateral (contra.) hemispheres was considered to represent
the amount of extravasated Evans blue, reflecting increased
vascular permeability in the infarct area. *** P,0.001; **P,0.01
(paired-t test).
(TIF)
Figure S2 Histological analysis of the PIT-LD mouse
liver. A, B. Liver surfaces of the photochemically-induced liver
damage in the WT (A) and the plasminogen KO mice (B) on days
1 and 7. Whereas the lesion volume was dramatically diminished
within one week in the WT liver, no significant change was
observed in the KO liver, as indicated in Fig. 3C, D. Scale bars:
1 mm. C, D. For evaluation of vascular permeability, Evans blue
administration was performed on the PIT-BD livers from WT and
KO mice. Two weeks following the surgical procedure, the
recovery process was observed in the WT liver, but not in the KO
liver. Note that the marginal area of the lesions (arrows) was
densely stained regardless of the genotype, and, consistent with the
HAA surrounding liver damage observed by CECT, dark staining
was continuously observed in the lesion area of the KO liver after
2 weeks (See Figure 3A). Scale bars: 1 mm. E, F. H&E-stained
images of the liver injury on days 7 and 14. Scale bars: 1 mm.
(TIF)
Figure S3 Comparative volumetric analyses of the
brain/liver lesions using CT and MRI. A. Representative
images of the brain or liver lesions of the same animals sequentially
acquired by CECT and MRI. B. Comparison of lesion volumes of
the same animals analyzed by two different image acquisition
techniques. Lesion volumes of the three different animal models
calculated from CECT (left, CT) and MR (right, MRI) images are
shown (n=4 each). There was no significant difference in the
lesion volumes between CECT and MR images in either model
(paired-t test, P.0.05).
(TIF)
Figure S4 Comparison of brain CT images of the same
animals acquired with or without contrast agents. CT
images of the same MCAO (upper) and PIT-BD (lower) mouse
brains acquired by simple CT (CT, left) or contrast-enhanced CT
(CECT, right). It is of note that although faint signals in the
ischemic areas of the brain are observed in the CT images, the
areas are significantly smaller than those detected by CECT.
(TIF)
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